media

In the Media

2020-09-16 // Synthetic biologists have created a slow-growing version of the coronavirus to give as a vaccine

Go to Article

2020-04-14 // African genomics startup 54gene raises $15M led by Adjuvant Capital

Go to Article

2020-04-14 // To accelerate innovation, the CDC should ease limits on which labs can handle the coronavirus

Go to Article

2020-04-14 // 54gene Closes $15M Series A

Go to Article

2020-04-10 // A New Front for Nationalism: The Global Battle Against a Virus

Go to Article

2020-03-24 // Private equity firms go after covid-19, repurposing portfolio company resources

Go to Article

Adjuvant seeks out the most innovative life sciences companies in the world.

See our Portfolio